GlassScriptPhysician profile
Kameron Shams
NPI 1679197180
$7,090.06
in general payments reported to CMS, 2019-2025
9 companies · $3,337 in 2025
The $3,337 reported for 2025 was more than what 78% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,400 · 2023: $159 · 2024: $1,193 · 2025: $3,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,593 · Grant: $1,050 · Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,593.13 |
| Grant | $1,050.00 |
| Food and Beverage | $1,046.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,478.00 | 2021-2025 | |
| Axogen | $2,003.92 | 2025 | |
| Skeletal Dynamics INC | $1,068.66 | 2024 | Align, Implate, Geminus |
| Medical Device Business Services, INC. | $1,050.00 | 2025 | |
| Stryker Corporation | $192.05 | 2023-2024 | Mako |
| Tulavi Therapeutics, INC. | $163.07 | 2025 | Allay Nerve Cap - Small Nerve Set |
| Globus Medical, INC. | $92.02 | 2024 | |
| United Orthopedics LLC | $25.89 | 2025 | |
| Integra Lifesciences Corporation | $16.45 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kameron Shams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.